References
- Cervellini I, Annenkov A, Brenton T, et al. Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor. Mol Med 2013;19(1):223–9.
- Merelli A, Czornyj L, Lazarowski A. Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases. Int J Neurosci 2015 Jan 9. doi:10.3109/00207454.2014.989321
- Mengozzi M, Ermilov P, Annenkov A, et al. Definition of a family of tissue-protective cytokines using functional cluster analysis: a proof-of-concept study. Front Immunol 2014;5(115):1–7.
- Ishibashi T, Dakin KA, Stevens B, et al. Astrocytes promote myelination in response to electrical impulses. Neuron 2006;49:823–32.
- Slaets H, Hendriks JJ, Stinissen P, et al. Therapeutic potential of LIF in multiple sclerosis. Trends Mol Med 2010 Nov;16(11):493–500.
- Davis ID, Kiers L, MacGregor L, et al. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. Clin Cancer Res 2005 Mar;11(5):1890–8.
- Segal BM, Constantinescu CS, Raychaudhuri A, et al. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008;7:796–804.
- The Lenercept Multiple Sclerosis Study Group and The University of British Colombia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999 Aug;53(3):457–65.
- Aguayo AJ, Rasminsky M, Bray GM, et al. Degenerative and regenerative responses of injured neurons in the central nervous system of adult mammals. Philos Trans R Soc Lond B Biol Sci 1991 Mar 29;331(1261):337–43.
- McKeon RJ, Schreiber RC, Rudge JS, Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 1991 Nov;11(11):3398–411.
- Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004;5:146–56.
- Lu D., Zador Z., Yao, J., Fazlollahi, F. and Manley, G. (2011) Aquaporin-4 Reduces Post-Traumatic Seizure Susceptibility by Promoting Astrocytic Glial Scar Formation in Mice. Journal of Neurotrauma, p.150127063153001.
- Kuhlmann T, Miron V, Cui Q, et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008;131:1749–58.
- Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 1998 Jan 15;18(2):601–9.
- Lee JK, Chow R, Xie F, et al. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration. J Neurosci 2010;30:10899–904.
- King CE, Rodger J, Bartlett C, et al. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol 2007;205:48–55.
- Topilko P, Schneider-Maunoury S, Levi G, et al. Krox-20 controls myelination in the peripheral nervous system. Nature 1994 Oct 27;371(6500):796–9.
- Emery B, Merson TD, Snell C, et al. SOCS3 negatively regulates LIF signaling in neural precursor cells. Mol Cell Neurosci 2006 Apr;31(4):739–47.
- Deverman BE, Patterson PH. Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination. J Neurosci 2012 Feb;32(6):2100–9.